Opdivo contains Nivolumabe, 40mg/4mL, 100mg/10mL, 240mg/24mL, supplied as injection. Manufacturer: Bristol Myers Squibb. Therapeutic class: Immunotherapy PD-1.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.